a nonsignificant trendP =0.100
By contrast, the unadjusted (crude) analysis showed only a nonsignificant trend toward benefit with BGC (OR, 1.65 [95% CI, 0.91–2.98]; P =0.100), as shown in Table 3 .
By contrast, the unadjusted (crude) analysis showed only a nonsignificant trend toward benefit with BGC (OR, 1.65 [95% CI, 0.91–2.98]; P =0.100), as shown in Table 3 .
However, this favorable shift did not reach statistical significance ( Figure S2 ).
In the overall unmatched cohort of 397 patients, the distribution of 90-day mRS scores showed a trend toward better functional outcomes in the BGC group than in the non-BGC group, but the difference was not statistically significant (adjusted common OR for worse outcome with BGC, 0.77 [95% CI, 0.51–1.16]; P =0.204).